Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
CAS NO.33419-42-0
1(10-100)Kilogram1(100-500)Kilogram2(500-1000)Kilogram
1. Certificate Of Analysis (COA)
2. Material Safety Data Sheet (MSDS)
3. Route of synthesis (ROS)
4. Method of Aanlysis (MOA)
5. Nuclear Magnetic Resonance (NMR)
6. Packing pictures and loading video before loading
7. Free Sample
9. Factory audit
10. Strong after-sale service
Etoposide Basic information |
Product Name: | Etoposide |
Synonyms: | VP-16;VP-16-213;4’-demethyl-epipodophyllotoxin-beta-d-ethyliden-glucosid;4’-demethylepipodophyllotoxinethylidene-beta-d-glucoside;4’-o-demethyl-1-o-(4,6-o-ethylidene-beta-d-glucopyranosyl)epipodophyllotoxin;9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydro;demethyl-epipodophyllotoxinethylideneglucoside;e[qr] |
CAS: | 33419-42-0 |
MF: | C29H32O13 |
MW: | 588.56 |
EINECS: | 251-509-1 |
Product Categories: | Pharmaceutical;Heterocycles;Antitumors for Research and Experimental Use;Biochemistry;Glucose;Sugars;Apoptosis;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Antitumour;Signalling;Apoptosis Inducers;Antibiotics;Carbohydrates & Derivatives;Chiral Reagents;PARADIONE;Antineoplastic;Anti-cancer&immunity;Inhibitors |
Mol File: | 33419-42-0.mol |
Etoposide Chemical Properties |
mp | 236-251 °C(lit.) |
refractive index | -110.5 ° (C=0.6, CHCl3) |
storage temp. | Store at RT |
solubility | DMSO: 30 mg/mL |
form | powder |
color | white |
Merck | 3886 |
EPA Substance Registry System | Furo[3',4': 6,7]naphtho[2,3-d]-1,3-dioxol- 6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-. beta.-D-glucopyranosyl]oxy]- 5,8,8a,9-tetrahydro-5-(4- hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-(33419-42-0) |
Safety Information |
Hazard Codes | T,Xi |
Risk Statements | 45-22-36/37/38 |
Safety Statements | 53-45-36/37-26 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | KC0190000 |
HazardClass | 6.1(a) |
PackingGroup | II |
Hazardous Substances Data | 33419-42-0(Hazardous Substances Data) |
MSDS Information |
Provider | Language |
---|---|
Etoposide | English |
SigmaAldrich | English |
Etoposide Usage And Synthesis |
Chemical Properties | White Crystalline Powder |
Usage | An antitumur agent that complexes with topoisomerase II and DNA to enhance double-strand and single strand cleavage of DNA and reversible inhitit religation. Blocks the cell cycle in S-phase and G2-phase of the cell cycle. Induces apoptosis in nor |
Usage | A DNA topoisomerase II inhibitor. Semi-synthetic derivative of podophyllotoxin, related structurally to Teniposide. Antineoplastic. |
Usage | anticonvulsant |
Biological Activity | Topoisomerase II inhibitor (IC 50 = 59.2 μ M). |
Etoposide Basic information |
Product Name: | Etoposide |
Synonyms: | VP-16;VP-16-213;4’-demethyl-epipodophyllotoxin-beta-d-ethyliden-glucosid;4’-demethylepipodophyllotoxinethylidene-beta-d-glucoside;4’-o-demethyl-1-o-(4,6-o-ethylidene-beta-d-glucopyranosyl)epipodophyllotoxin;9-((4,6-o-ethylidine-beta-d-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydro;demethyl-epipodophyllotoxinethylideneglucoside;e[qr] |
CAS: | 33419-42-0 |
MF: | C29H32O13 |
MW: | 588.56 |
EINECS: | 251-509-1 |
Product Categories: | Pharmaceutical;Heterocycles;Antitumors for Research and Experimental Use;Biochemistry;Glucose;Sugars;Apoptosis;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Antitumour;Signalling;Apoptosis Inducers;Antibiotics;Carbohydrates & Derivatives;Chiral Reagents;PARADIONE;Antineoplastic;Anti-cancer&immunity;Inhibitors |
Mol File: | 33419-42-0.mol |
Etoposide Chemical Properties |
mp | 236-251 °C(lit.) |
refractive index | -110.5 ° (C=0.6, CHCl3) |
storage temp. | Store at RT |
solubility | DMSO: 30 mg/mL |
form | powder |
color | white |
Merck | 3886 |
EPA Substance Registry System | Furo[3',4': 6,7]naphtho[2,3-d]-1,3-dioxol- 6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-. beta.-D-glucopyranosyl]oxy]- 5,8,8a,9-tetrahydro-5-(4- hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-(33419-42-0) |
Safety Information |
Hazard Codes | T,Xi |
Risk Statements | 45-22-36/37/38 |
Safety Statements | 53-45-36/37-26 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | KC0190000 |
HazardClass | 6.1(a) |
PackingGroup | II |
Hazardous Substances Data | 33419-42-0(Hazardous Substances Data) |
MSDS Information |
Provider | Language |
---|---|
Etoposide | English |
SigmaAldrich | English |
Etoposide Usage And Synthesis |
Chemical Properties | White Crystalline Powder |
Usage | An antitumur agent that complexes with topoisomerase II and DNA to enhance double-strand and single strand cleavage of DNA and reversible inhitit religation. Blocks the cell cycle in S-phase and G2-phase of the cell cycle. Induces apoptosis in nor |
Usage | A DNA topoisomerase II inhibitor. Semi-synthetic derivative of podophyllotoxin, related structurally to Teniposide. Antineoplastic. |
Usage | anticonvulsant |
Biological Activity | Topoisomerase II inhibitor (IC 50 = 59.2 μ M). |